US 8765125
Methods of treating autoimmune diseases with Dll4 antagonists
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 8765125 (Methods of treating autoimmune diseases with Dll4 antagonists) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P